Micevic, G., Theodosakis, N., & Bosenberg, M. (2017). Aberrant DNA methylation in melanoma: Biomarker and therapeutic opportunities. Clin Epigenetics.
Style de citation ChicagoMicevic, Goran, Nicholas Theodosakis, et Marcus Bosenberg. "Aberrant DNA Methylation in Melanoma: Biomarker and Therapeutic Opportunities." Clin Epigenetics 2017.
Style de citation MLAMicevic, Goran, Nicholas Theodosakis, et Marcus Bosenberg. "Aberrant DNA Methylation in Melanoma: Biomarker and Therapeutic Opportunities." Clin Epigenetics 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.